| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 09/18/1997 | WO1997025351A3 INHIBITORS OF MAdCAM-1-MEDIATED INTERACTIONS AND METHODS OF USE THEREFOR |
| 09/18/1997 | CA2249733A1 Spirocycle integrin inhibitors |
| 09/18/1997 | CA2249011A1 Bioconjugates of manganese or iron complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide |
| 09/18/1997 | CA2248964A1 Iron complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide |
| 09/18/1997 | CA2248927A1 Smooth muscle cell lim protein |
| 09/18/1997 | CA2248586A1 Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| 09/18/1997 | CA2248551A1 Programmed cell death and interleukin-1.beta. |
| 09/18/1997 | CA2248549A1 Extracellular matrix signalling molecules |
| 09/18/1997 | CA2248538A1 Targeted delivery of genes encoding interferon |
| 09/18/1997 | CA2248355A1 Human membrane antigen tm4 superfamily protein and dna encoding this protein |
| 09/18/1997 | CA2247888A1 Human bikunin |
| 09/18/1997 | CA2247822A1 Methods of treating or preventing interstitial cystitis |
| 09/18/1997 | CA2246427A1 Methods for treatment of allergic diseases with ige |
| 09/17/1997 | EP0795547A1 (Aminoalkyl- and acylaminoalkyl-oxy)benzyloxyquinolines, process for their preparation and use as Bradykinin receptor antagonists |
| 09/17/1997 | EP0795334A2 Prodrugs for the treatment tumors and inflammatory diseases |
| 09/17/1997 | EP0795017A1 Hippocampus-associated proteins, dna sequences coding therefor and uses thereof |
| 09/17/1997 | EP0795006A1 HUMAN MutT2 |
| 09/17/1997 | EP0794963A2 A method of identifying cftr-binding compounds useful for activating chloride conductance in animal cells |
| 09/17/1997 | EP0794956A1 Substituted 2-(phosphinyloxymethyl)-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof |
| 09/17/1997 | EP0794953A1 Quinazoline derivatives |
| 09/17/1997 | EP0794951A1 Processes and intermediates for preparing cis(+)3- 4,-6-dihydroxychroman-3-ylmethyl]-4-methoxyaniline |
| 09/17/1997 | EP0794949A1 Novel 3,5-dioxo-(2h,4h)-1,2,4-triazine derivatives, their preparation and use as drugs |
| 09/17/1997 | EP0794944A1 Perhydroisoindole derivatives as antagonists of substance p |
| 09/17/1997 | EP0794797A1 Methods and devices for immunizing a host through administration of naked polynucleotides which encode antigenic peptides |
| 09/17/1997 | EP0794790A1 Localized delivery of factors enhancing survival of transplanted cells |
| 09/17/1997 | EP0794789A1 Inhibitors of prenyl transferases |
| 09/17/1997 | EP0794784A1 Combination chemotherapy of suramin and a vinca-alkaloid or estramustine |
| 09/17/1997 | EP0794782A1 Cobalt schiff base compounds |
| 09/17/1997 | EP0794780A1 Quinazolinone-containing pharmaceutical compositions and methods for the use thereof |
| 09/17/1997 | EP0794776A2 Use of rifabutin and a combination of rifabutin and atovaquone in the treatment of pneumocystis carinii infections |
| 09/17/1997 | EP0794774A1 4,4-(disubstituted)cyclohexan-1-ols monomers and related compounds |
| 09/17/1997 | EP0794772A1 A method for enhancing outflow of aqueous humor in treatment of glaucoma |
| 09/17/1997 | EP0794771A1 Method of using triaryl-ethylene derivatives in the treatment and prevention of osteoporosis |
| 09/17/1997 | EP0755675B1 Dermatological and/or pharmaceutical composition, process of preparation and utilization |
| 09/17/1997 | EP0711164B1 4-aza-pregnane 5-alpha-reductase isozyme 1 inhibitors |
| 09/17/1997 | EP0707475B1 Extended release, film-coated tablet of astemizole and pseudoephedrine |
| 09/17/1997 | EP0698022B1 1,4-benzoxazine derivatives as potassium channel openers |
| 09/17/1997 | EP0696283B1 2-, 3-, 4-, 5-, 6-, 7-, 8-, 9- and/or 10-substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use |
| 09/17/1997 | EP0635009B1 Novel derivatives of 2,3-dihydro-2,2,4,6,7-pentaalkyl-5-benzofuranols |
| 09/17/1997 | CN1159830A Immunomodulators |
| 09/17/1997 | CN1159808A Spiro-azabicyclic compounds useful in therapy |
| 09/17/1997 | CN1159805A Nvel imidazole derivatives, method for preparing same, novel intermediates thus obtained, medicinal applications of same and pharmaceutical compositions containing same |
| 09/17/1997 | CN1159804A Dihydrobenzofuranes |
| 09/17/1997 | CN1159797A Aryloxy and arylthiopropanolamine derivative suseful as beta 3-adrenoreceptor agonists and antagonists of the beta 1 and beta 2-adrenoreceptors and pharmaceutical composition thereof |
| 09/17/1997 | CN1159758A Peptide, a method of obtaining it and a pharmaceutical compound based on it |
| 09/17/1997 | CN1159753A Anti-acne cosmetic compositions |
| 09/17/1997 | CN1159444A Sulfuryl amino substituted benzoyl guanidine, preparation process and applications as medicine or diagnostic agent and the medicine containing same |
| 09/16/1997 | US5668180 Alkoxyaryl compounds |
| 09/16/1997 | US5668172 Anthraquinone pharmaceutical compounds and uses therefor |
| 09/16/1997 | US5668157 Cyanoguanidines as K-channel blockers |
| 09/16/1997 | US5668152 Protein kinase C inhibitors |
| 09/16/1997 | US5668151 Useful as anorexigenic agents in promoting weight loss and treating eating disorders |
| 09/16/1997 | US5668150 Antiallergy, antiinflammatory |
| 09/16/1997 | US5668143 Heterocyclic benzenesulfonylimine derivatives as inhibitors of IL-1 action |
| 09/16/1997 | US5668139 Xanthine derivatives |
| 09/16/1997 | US5668138 Affinity for sigma receptors, central nervous system disorders |
| 09/16/1997 | US5668137 N-heterocyclic sulfonamides having endothelin receptor activity |
| 09/16/1997 | US5668129 N-substituted azaheterocyclic carboxylic acids and esters thereof |
| 09/16/1997 | US5668126 Bile acid derivatives, processes for their preparation, and use as pharmaceuticals |
| 09/13/1997 | CA2199771A1 Aminoalkyl and acylaminoalkyl ethers, process for their preparation, and their use as bradykinin receptor antagonists |
| 09/12/1997 | WO1997032989A2 Recombinant aav vector-based transduction system and use of same |
| 09/12/1997 | WO1997032981A1 Down-regulation resistant c3 convertase |
| 09/12/1997 | WO1997032979A1 Inhibition of proliferation of cells |
| 09/12/1997 | WO1997032884A1 Meso-substituted tripyrrane compounds, compositions, and methods for making and using the same |
| 09/12/1997 | WO1997032883A1 Azolobenzazepine derivatives as neurologically active agents |
| 09/12/1997 | WO1997032882A1 PYRIMIDO[5,4-d]PYRIMIDINES, MEDICAMENTS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PRODUCTION |
| 09/12/1997 | WO1997032881A1 4-amino pyrimidine derivates, medicaments containing these compounds, their use and process for their production |
| 09/12/1997 | WO1997032880A1 Pyrimido[5,4-d]pyrimidines, medicaments containing these compounds, their use and process for their production |
| 09/12/1997 | WO1997032874A1 Novel sulphur derivatives comprising an amide bond, method for preparing same, use thereof as drugs, and pharmaceutical compositions containing such derivatives |
| 09/12/1997 | WO1997032873A1 Quinoxalinediones |
| 09/12/1997 | WO1997032872A1 Compounds with a sulfamate group |
| 09/12/1997 | WO1997032871A1 Tricyclic compounds, their production and use |
| 09/12/1997 | WO1997032865A1 Novel aryl glycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds |
| 09/12/1997 | WO1997032856A1 4-anilinoquinazoline derivatives |
| 09/12/1997 | WO1997032853A1 Triaryl compounds |
| 09/12/1997 | WO1997032849A1 Sulphur derivatives with a retroamide bond as endothelin-converting enzyme inhibitors |
| 09/12/1997 | WO1997032846A1 Hydroxamic acid derivatives for use with the treatment of diseases related to connective tissue degradation |
| 09/12/1997 | WO1997032603A1 Recombinant constructs encoding t cell receptors specific for human hla-restricted tumor antigens |
| 09/12/1997 | WO1997032598A2 Vaccines |
| 09/12/1997 | WO1997032591A1 Method of promoting bone growth with hyaluronic acid and growth factors |
| 09/12/1997 | WO1997032585A1 Combinational therapeutic methods employing nitric oxide scavengers and compositions useful therefor |
| 09/12/1997 | WO1997032582A1 Compositions and use of benzamides and nicotinamides as anti-inflammatory agents |
| 09/12/1997 | WO1997032581A1 Use of 4-phenyl-3,6-dihydro-2h-pyridyl derivatives as nmda receptor subtype blockers |
| 09/12/1997 | WO1997032576A1 Use of aryl n-substituted carboxamides to kill tumors |
| 09/12/1997 | WO1997032575A1 Mercapto derivatives as inhibitors of cyclooxygenases |
| 09/12/1997 | WO1997025421A3 PROTEIN INDUCED BY DEPRENYL$m(3) |
| 09/12/1997 | WO1997021826A3 Complementary adenoviral vector systems and cell lines |
| 09/12/1997 | WO1997004097A3 Human CTLA-8 and uses of CTLA-8-related proteins |
| 09/12/1997 | CA2249546A1 Triaryl compounds and their use as antiinflammatory |
| 09/12/1997 | CA2248720A1 Pyrimido[5,4-d]pyrimidines, pharmaceuticals containing these compounds, their use and processes for the preparation thereof |
| 09/12/1997 | CA2248350A1 Inhibition of proliferation of cells |
| 09/12/1997 | CA2248316A1 Pyrimido[5,4-d]pyrimidines, pharmaceuticals containing these compounds, their use and processes for their preparation |
| 09/12/1997 | CA2248188A1 Sulphur derivatives with a retroamide bond as endothelin-converting enzyme inhibitors |
| 09/12/1997 | CA2248187A1 Novel sulphur derivatives comprising an amide bond, method for preparing same, use thereof as drugs, and pharmaceutical compositions containing such derivatives |
| 09/12/1997 | CA2248134A1 Use of 4-phenyl-3,6-dihydro-2h-pyridyl derivatives as nmda receptor subtype blockers |
| 09/12/1997 | CA2248125A1 Compositions and use of benzamides and nicotinamides as anti-inflammatory agents |
| 09/12/1997 | CA2248109A1 Use of aryl n-substituted carboxamides to kill tumors |
| 09/12/1997 | CA2247615A1 Down-regulation resistant c3 convertase |
| 09/12/1997 | CA2247453A1 Azolobenzazepine derivatives as neurologically active agents |
| 09/12/1997 | CA2246333A1 Recombinant constructs encoding t cell receptors specific for human hla-restricted tumor antigens |